AGT and cardiac hypertrophy: Importantly, in the SHR AGT, siRNA did lower cardiac Ang II and cardiac hypertrophy.7 However, the main determinant of the latter appeared to be the reduction in blood pressure, rather than the disappearance of cardiac Ang II.